TGF-β1 induces epithelial-to-mesenchymal transition via inhibiting mitochondrial functions in A549 cells

References

• Heerboth S, Housman G, Leary M, et al. EMT and tumor metastasis. Clin Trans Med. 2015;4:6.
   PubMed Web of Science ®Google Scholar
• Fedele M, Cerchia L, Chiappetta G. The epithelial-to-mesenchymal transition in breast cancer: focus on basal-like carcinomas. Cancers. 2017;9:134
   Web of Science ®Google Scholar
• Skrypek N, Goossens S, De Smedt E, et al. Epithelial-to-mesenchymal transition: epigenetic reprogramming driving cellular plasticity. Trends Genet. 2017;33:943–959.
   PubMed Web of Science ®Google Scholar
• Wang H, Yao L, Gong Y, et al. TRIM31 regulates chronic inflammation via NF-κB signal pathway to promote invasion and metastasis in colorectal cancer. Am J Transl Res. 2018;10:1247–1259.
   PubMed Web of Science ®Google Scholar
• Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009;19:156–172.
   PubMed Web of Science ®Google Scholar
• Cai Z, Cao Y, Luo Y, et al. Signalling mechanism(s) of epithelial–mesenchymal transition and cancer stem cells in tumour therapeutic resistance. Clin Chim Acta. 2018;483:156–163.
   PubMed Web of Science ®Google Scholar
• Bocchino M, Agnese S, Fagone E, et al. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. PLos One. 2010;5:e14003.
   PubMed Web of Science ®Google Scholar
• Ryoo IG, Ha H, Kwak MK. Inhibitory role of the KEAP1-NRF2 pathway in TGFβ1-stimulated renal epithelial transition to fibroblastic cells: a modulatory effect on SMAD signaling. PLos One. 2014;9:e93265.
   PubMed Web of Science ®Google Scholar
• Boudreau HE, Casterline BW, Rada B, et al. Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells. Free Radic Biol Med. 2012;53:1489–1499.
   PubMed Web of Science ®Google Scholar
• Nickel A, Kohlhaas M, Maack C. Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol. 2014;73:26–33.
   PubMed Web of Science ®Google Scholar
• Chaturvedi RK, Flint Beal M. Mitochondrial diseases of the brain. Free Radic Biol Med. 2013;63:1–29.
   PubMed Web of Science ®Google Scholar
• Akbar M, Essa MM, Daradkeh G, et al. Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress. Brain Res. 2016;1637:34–55.
   PubMed Web of Science ®Google Scholar
• Chaturvedi RK, Beal MF. Mitochondria targeted therapeutic approaches in Parkinson’s and Huntington’s diseases. Mol Cell Neurosci. 2013;55:101–114.
   PubMed Web of Science ®Google Scholar
• Favre C, Zhdanov A, Leahy M, et al. Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells. Oncogene. 2010;29:3964–3976.
   PubMed Web of Science ®Google Scholar
• Kinugasa H, Whelan KA, Tanaka K, et al. Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression. Oncogene. 2015;34:5229–5239.
   PubMed Web of Science ®Google Scholar
• He K, Guo X, Liu Y, et al. TUFM downregulation induces epithelial–mesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPK-GSK3β signaling. Cell Mol Life Sci. 2016;73:2105–2121.
   PubMed Web of Science ®Google Scholar
• Shagieva G, Domnina L, Makarevich O, et al. Depletion of mitochondrial reactive oxygen species downregulates epithelial-to-mesenchymal transition in cervical cancer cells. Oncotarget. 2017;8:4901–4913.
   PubMedGoogle Scholar
• Stallons LJ, Whitaker RM, Schnellmann RG. Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis. Toxicol Lett. 2014;224:326–332.
   PubMed Web of Science ®Google Scholar
• Gambini J, Inglés M, Olaso G, et al. Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. 2015;2015:1.
   Web of Science ®Google Scholar
• Wang H, Zhang H, Tang L, et al. Resveratrol inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology. 2013;303:139–146.
   PubMed Web of Science ®Google Scholar
• He T, Xiong J, Nie L, et al. Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway. J Mol Med. 2016;94:1359–1371.
   PubMed Web of Science ®Google Scholar
• Jing Y, Han Z, Zhang S, et al. Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci. 2011;1:29.
   PubMed Web of Science ®Google Scholar
• Lu J, Tan M, Cai Q. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2015;356:156–164.
   PubMed Web of Science ®Google Scholar
• Islam MN, Das SR, Emin MT, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18:759–765.
   PubMed Web of Science ®Google Scholar
• Katz LH, Li Y, Chen J-S, et al. Targeting TGF-β signaling in cancer. Expert Opin Ther Targets. 2013;17:743–760.
   PubMed Web of Science ®Google Scholar
• Zhang J, Tian XJ, Xing J. Signal transduction pathways of EMT induced by TGF-β, SHH, and WNT and their crosstalks. JCM. 2016;5:41.
   Google Scholar
• Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS Release. Physiol Rev. 2014;94:909–950.
   PubMed Web of Science ®Google Scholar
• Indo HP, Yen H-C, Nakanishi I, et al. A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr. 2015;56:1–7.
   PubMed Web of Science ®Google Scholar
• Wu YT, Wu SB, Wei YH. Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases. CPD. 2014;20:5510–5526.
   Google Scholar
• Xiong N, Long X, Xiong J, et al. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models. Crit Rev Toxicol. 2012;42:613–632.
   PubMed Web of Science ®Google Scholar
• Indo HP, Davidson M, Yen H-C, et al. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion. 2007;7:106–118.
   PubMed Web of Science ®Google Scholar
• Zielonka J, Kalyanaraman B. Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med. 2010;48:983–1001.
   PubMed Web of Science ®Google Scholar
• Robinson KM, Janes MS, Pehar M, et al. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci USA. 2006;103:15038–15043.
   PubMed Web of Science ®Google Scholar
• Miriyala S, Spasojevic I, Tovmasyan A, et al. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta. 2012;1822:794–814.
   PubMed Web of Science ®Google Scholar
• Huang H-F, Guo F, Cao Y-Z, et al. Neuroprotection by manganese superoxide dismutase (MnSOD) mimics: antioxidant effect and oxidative stress regulation in acute experimental stroke. CNS Neurosci Ther. 2012;18:811–818.
   PubMed Web of Science ®Google Scholar
• Sharma SS, Gupta S. Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation. Eur J Pharmacol. 2007;561:72–79.
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Sonntag WE, de Cabo R, et al. Mitochondrial protection by resveratrol. Exer Sport Sci Rev. 2011;39:128–132.
   PubMed Web of Science ®Google Scholar
• Malhotra A, Bath S, Elbarbry F. An organ system approach to explore the antioxidative, anti-inflammatory, and cytoprotective actions of resveratrol. Oxid Med Cell Longev. 2015;2015:1.
   Web of Science ®Google Scholar
• Nwachukwu JC, Srinivasan S, Bruno NE, et al. Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network. eLife. 2014;3:e02057.
   PubMed Web of Science ®Google Scholar
• Liu FC, Tsai HI, Yu HP. Organ-protective effects of red wine extract, resveratrol, in oxidative stress-mediated reperfusion injury. Oxid Med Cell Longev. 2015;2015:1.
   Google Scholar
• de Oliveira MR, Nabavi SF, Manayi A, et al. Resveratrol and the mitochondria: from triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view. Biochim Biophys Acta. 2016;1860:727–745.
   PubMed Web of Science ®Google Scholar
• Ji Q, Liu X, Han Z, et al. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-beta1/Smads signaling pathway mediated Snail/E-cadherin expression. BMC Cancer. 2015;15:97.
   PubMed Web of Science ®Google Scholar
• Kennedy ED, Maechler P, Wollheim CB. Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. Diabetes. 1998;47:374–380.
   PubMed Web of Science ®Google Scholar